Enablex
® (
darifenacin) is a prescription medication approved for the treatment of
overactive bladder. Specifically, it is approved to help treat the following overactive bladder symptoms:
- Frequent urination (usually defined as needing to go more than eight times in 24 hours)
- Sudden, frequent urges to urinate
- Leaking accidents (known as urinary incontinence or urge incontinence).
Who Makes Enablex?
It is made by Novartis Pharmaceuticals Corporation.
Enablex belongs to a group of medications known as antimuscarinics or anticholinergics. It works by blocking specific receptors in the bladder, called muscarinic receptors, which helps the muscles of the bladder to relax. Since an overactive bladder is often due to muscle
contractions that are too frequent and uncontrollable, Enablex can help relieve many of the related symptoms.
Studies have shown Enablex to be effective in relieving many of the symptoms of an overactive bladder. In clinical studies, people who took the drug significantly reduced the frequency of wetting accidents. In addition, people who took it used the bathroom less frequently and were able to pass more urine each time (the frequent muscle contractions of an overactive bladder usually prevent the bladder from holding a normal amount of urine).